Vertex Pharmaceuticals Inc banner

Vertex Pharmaceuticals Inc
SWB:VX1

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
SWB:VX1
Watchlist
Price: 371.7 EUR -5.37% Market Closed
Market Cap: €44B

Wall St Price Targets

VX1 Price Targets Summary
Vertex Pharmaceuticals Inc

Wall Street analysts forecast VX1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VX1 is 473.67 EUR with a low forecast of 282.62 EUR and a high forecast of 570.7 EUR.

Lowest Forecast
Price Target
282.62 EUR
24% Downside
Average Forecast
Price Target
473.67 EUR
27% Upside
Highest Forecast
Price Target
570.7 EUR
54% Upside
Vertex Pharmaceuticals Inc Competitors:
Price Targets
AFYA
Afya Ltd
20% Upside
LGI
Lgi Ltd
33% Upside

Revenue
Forecast

17% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.

Operating Income
Forecast

24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 8 years is 15%.

Net Income
Forecast

42% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
42% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VX1's stock price target?
Price Target
473.67 EUR

According to Wall Street analysts, the average 1-year price target for VX1 is 473.67 EUR with a low forecast of 282.62 EUR and a high forecast of 570.7 EUR.

What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%

Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.

What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 8 years is 15%.

What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett